Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
American Journal of Clinical Dermatology|March 18, 2017
Morphea and Eosinophilic Fasciitis: An UpdateJorre S Mertens, Marieke M B Seyger, Rogier M Thurlings, et al.Journal of the American Academy of Dermatology|July 24, 2017
Long-term outcome of eosinophilic fasciitis: A cross-sectional evaluation of 35 patientsJorre S Mertens, Rogier M Thurlings, Wietske Kievit, et al.Skin Health and Disease|September 12, 2022
3D stereophotogrammetry in children and adolescents with Scleroderma En Coup De Sabre/Parry-Romberg Syndrome: Description of a novel method for monitoring disease progressionRutger Ter Horst, Thomas J J Maal, Martien J J de Koning, et al.Acta Dermato-Venereologica|December 14, 2018
Beliefs About Medicines in Patients with Psoriasis Treated with Methotrexate or Biologics: A Cross-sectional Survey StudyMarisol E Otero, Juul M P A van den Reek, Peter C M van de Kerkhof, et al.Acta Dermato-Venereologica|March 18, 2016
Drug Survival and Predictors of Drug Survival for Methotrexate Treatment in a Retrospective Cohort of Adult Patients with Localized SclerodermaJorre S Mertens, Juul M van den Reek, Wietske Kievit, et al.Acta Dermato-Venereologica|November 20, 2015
Use of Mycophenolate Mofetil in Patients with Severe Localized Scleroderma Resistant or Intolerant to MethotrexateJorre S Mertens, Diane Marsman, Peter C M van de Kerkhof, et al.Arthritis & Rheumatology (Hoboken, N.J.)|April 24, 2019
Induction of Inflammation and Fibrosis by Semaphorin 4A in Systemic SclerosisTiago Carvalheiro, Alsya J Affandi, Beatriz Malvar-Fernández, et al.JAMA Dermatology|August 20, 2016
High-Dose Intravenous Pulse Methotrexate in Patients With Eosinophilic FasciitisJorre S Mertens, Manon C Zweers, Wietske Kievit, et al.European Journal of Immunology|December 17, 2019
cDC2 and plasmacytoid dendritic cells diminish from tissues of patients with non-Hodgkin orbital lymphoma and idiopathic orbital inflammationKamil G Laban, Rianne Rijken, Sanne Hiddingh, et al.Annals of the Rheumatic Diseases|September 7, 2018
Galectin-9 is an easy to measure biomarker for the interferon signature in systemic lupus erythematosus and antiphospholipid syndromeLucas L van den Hoogen, Joël A G van Roon, Jorre S Mertens, et al.Pageof 2